Home LiteratureArticle Details
PMID: 679504 Published · ppublish English Journal Article

Bromocriptine treatment of males with pituitary tumours, hyperprolactinaemia, and hypogonadism.

Clinical endocrinology ·Vol. 9 ·No. 1 ·1978-07-00 ·Pages 73-9

Nagulesparen M, Ang V, Jenkins JS

Abstract

Plasma prolactin concentrations were measured in thirty-four males with pituitary tumours and twenty-two patients (65%) were found to have hyperprolactinaemia. Plasma testosterone concentrations were subnormal in twenty-nine patients. Ten patients with hyperprolactinaemia were treated with bromocriptine; prolactin was restored to normal values in eight patients but testosterone secretion remained deficient. Two patients were resistant to bromocriptine. Some improvement in libido and potency was obtained after restoration of normal prolactin concentrations in four cases in spite of persistently low testosterone secretion. For maximal improvement in sexual function treatment with both bromocriptine and testosterone was required.

MeSH Terms
Bromocriptine/therapeutic use Humans Hypogonadism/drug therapy Male Pituitary Neoplasms/drug therapy Prolactin/blood Sexual Behavior/drug effects Testosterone/deficiency
Chemicals
Bromocriptine Testosterone Prolactin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Nagulesparen M
Ang V
Jenkins J S
Article Info
Journal
Clinical endocrinology
Abbr.
Clin Endocrinol (Oxf)
ISSN
0300-0664
Published
1978-07-00
Pages
73-9
Language
English
Region
England
NLM ID
0346653
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com